RecruitingPhase 3NCT07221851
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Studying Turner syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ascendis Pharma A/S
- Principal Investigator
- Medical Director, MDAscendis Pharma A/S
- Intervention
- Lonapegsomatropin [SKYTROFA®](combination_product)
- Enrollment
- 186 enrolled
- Eligibility
- 2-17 years · All sexes
- Timeline
- 2025 – 2029
Study locations (5)
- Ascendis Pharma Investigational Site, Centennial, Colorado, United States
- Ascendis Pharma Investigational Site, Orlando, Florida, United States
- Ascendis Pharma Investigational Site, Idaho Falls, Idaho, United States
- Ascendis Pharma Investigational Site, Saint Paul, Minnesota, United States
- Ascendis Pharma Investigational Site, San Antonio, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07221851 on ClinicalTrials.govOther trials for Turner syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07502586Turner Syndrome: Genetic ConsiderationsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- RECRUITINGNCT07344012Parental Project Amongst 93 Patients With Turner SyndromeUniversity Hospital, Strasbourg, France
- RECRUITINGPHASE4NCT06834594Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner SyndromeChildren's Mercy Hospital Kansas City
- RECRUITINGNCT06507007Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner SyndromeGødstrup Hospital
- RECRUITINGNCT06794190Characterization of Hepatopathy in Turner Syndrome: Analysis of DeterminantsIRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGPHASE2NCT06668805A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone TreatmentBioMarin Pharmaceutical
- RECRUITINGPHASE2NCT05849389Vosoritide for Short Stature in Turner SyndromeRoopa Kanakatti Shankar, MBBS, MS
- RECRUITINGNANCT06202846Identification of Y Chromosome From Free Circulating DNA in Patients With Turner SyndromeUniversity Hospital, Strasbourg, France